ロード中...
EFFECTS OF THE NICOTINIC RECEPTOR ANTAGONIST MECAMYLAMINE ON AD-LIB SMOKING BEHAVIOR, TOPOGRAPHY, AND NICOTINE LEVELS IN SMOKERS WITH AND WITHOUT SCHIZOPHRENIA: A PRELIMINARY STUDY
Individuals with schizophrenia have higher plasma nicotine levels in comparison to non-psychiatric smokers, even when differences in smoking are equated. This difference may be related to how intensely cigarettes are smoked but this has not been well-studied. Mecamylamine (MEC), a non-competitive ni...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2784178/ https://ncbi.nlm.nih.gov/pubmed/19700263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2009.07.019 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|